Biohaven Therapeutics Ltd.

This study tested the long-term safety of an experimental drug called BHV-7000 in people with bipolar I disorder. It was designed for people who had already completed an earlier study of the same drug. The study was terminated early, so results are limited. Key goals were to chec…

This study tested whether the drug BHV-7000 could help reduce seizures in people with a type of generalized epilepsy. It included 27 adults aged 18 to 75. The trial was stopped early, so results are limited.